Your browser doesn't support javascript.
loading
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
Militello, Anna Maria; Orsi, Giulia; Cavaliere, Alessandro; Niger, Monica; Avallone, Antonio; Salvatore, Lisa; Tortora, Giampaolo; Rapposelli, Ilario Giovanni; Giordano, Guido; Noventa, Silvia; Giommoni, Elisa; Bozzarelli, Silvia; Macchini, Marina; Peretti, Umberto; Procaccio, Letizia; Puccini, Alberto; Cascinu, Stefano; Montagna, Cristina; Milella, Michele; Reni, Michele.
Afiliação
  • Militello AM; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20123, Milan, Italy.
  • Orsi G; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Cavaliere A; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20123, Milan, Italy.
  • Niger M; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Avallone A; Department of Oncology, University of Torino, Candiolo, Italy.
  • Salvatore L; Candiolo Cancer Institute, FPO - IRCCS Candiolo, Candiolo, Italy.
  • Tortora G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.
  • Rapposelli IG; Biologia Cellulare e Bioterapie, Istituto Nazionale per lo Studio e la Cura dei Tumori ''Fondazione Giovanni Pascale'' - IRCCS, Naples, Italy.
  • Giordano G; Unit of Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario, Agostino Gemelli IRCCS, Rome, Italy.
  • Noventa S; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Giommoni E; Unit of Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario, Agostino Gemelli IRCCS, Rome, Italy.
  • Bozzarelli S; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Macchini M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) ''Dino Amadori'', Meldola, Italy.
  • Peretti U; Unit of Medical Oncology and Biomolecular Therapy, Policlinico Riuniti, Foggia, Italy.
  • Procaccio L; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Puccini A; Department of Medical Oncology, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
  • Cascinu S; Medical Oncology Division, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • Montagna C; Department of Medical Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Milella M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20123, Milan, Italy.
  • Reni M; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
Cancer Chemother Pharmacol ; 92(6): 501-510, 2023 12.
Article em En | MEDLINE | ID: mdl-37725113
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália